The Trump administration aims to change the Medicare Drug Price Negotiation Program in a way that would delay when certain ...

In a new report, the Peterson Center on Healthcare made policy recommendations on reimbursement, access and data collection ...

The digital health funding market has been way up and way down over the past five years. As this roller coaster starts to settle down, one thing is clear to Randy Bolyga: that the industry is ...

About a third of small businesses discontinue their health insurance coverage from one year to the next, new research from ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

The Trump administration is not finalizing a Biden-era provision that would expand coverage of anti-obesity drugs under ...

The next wave of metabolic medicines in development includes oral GLP-1 drugs that work comparably to currently available injectable medicines, and Eli Lilly is taking the lead with Phase 3 ...

The Supreme Court will soon hear oral arguments for a case that threatens coverage of preventive services without ...

The scent of eucalyptus oil wafts through more households than ever. Herbal teas promising immunity boosts line mainstream grocery store shelves. Social media teems with influencers touting the ...

As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and mass layoffs throughout the FDA raise concerns about the agency’s ability to ...

With rising operational costs, major shifts in Medicaid, and other financial pressures bearing down on the healthcare system, forecasting revenue and allocating resources effectively has never ...

Newell shared insights from his experience at Jiff and subsequent aquisition by Castlight Health in the runup to the MedCity ENGAGE conference where he will be part of a panel discussion on ...